Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Porterfield

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Atrial Fibrillation|December 14, 2016
Who Needs Pharmacologic Therapy?Christopher P Porterfield, Rohit Malhotra
Journal of Cardiovascular Electrophysiology|March 13, 2015
Arrhythmia in cardiac sarcoidosisChristopher P Porterfield, John D Ferguson
Clinical Cardiology|November 14, 2009
Quartiles of peak troponin are associated with long-term risk of death in type 1 and STEMI, but not in type 2 or NSTEMI patientsManuel A Gonzalez, Christopher P Porterfield, Dana J Eilen, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 19, 2011
The universal classification is an independent predictor of long-term outcomes in acute myocardial infarctionManuel A Gonzalez, Dana J Eilen, Rana A Marzouq, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 29, 2011
Reliability using the universal classification of acute myocardial infarction compared to ST-segment classificationManuel A Gonzalez, Rana A Marzouq, Summiyah Nasir, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Atrial Fibrillation|December 14, 2016
Who Needs Pharmacologic Therapy?Christopher P Porterfield, Rohit Malhotra
Journal of Cardiovascular Electrophysiology|March 13, 2015
Arrhythmia in cardiac sarcoidosisChristopher P Porterfield, John D Ferguson
Clinical Cardiology|November 14, 2009
Quartiles of peak troponin are associated with long-term risk of death in type 1 and STEMI, but not in type 2 or NSTEMI patientsManuel A Gonzalez, Christopher P Porterfield, Dana J Eilen, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 19, 2011
The universal classification is an independent predictor of long-term outcomes in acute myocardial infarctionManuel A Gonzalez, Dana J Eilen, Rana A Marzouq, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 29, 2011
Reliability using the universal classification of acute myocardial infarction compared to ST-segment classificationManuel A Gonzalez, Rana A Marzouq, Summiyah Nasir, et al.
Pageof 1